Company profile
Accelerating Cancer Immunotherapy Research company profile
Accelerating Cancer Immunotherapy Research (ACIR) focuses on expediting cancer immunotherapy research by providing researchers with up-to-date literature and insights in the field. The organization aims to keep scientists informed about the latest developments and breakthroughs in cancer immunotherapy, facilitating faster and more effective research outcomes. ACIR serves as a valuable resource for the scientific community, offering curated content and expert analysis to support ongoing research efforts in combating cancer through immunotherapy.
Business identity
- Website
- https://www.acir.org
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- Non Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2011-01-01
Headquarters
- Headquarters
- Townshend, Vermont, United States
- Postal code
- 01742
- Country code
- US
- Continent
- North America